CHRISTIE BALLANTYNE to Glucagon-Like Peptide-1 Receptor
This is a "connection" page, showing publications CHRISTIE BALLANTYNE has written about Glucagon-Like Peptide-1 Receptor.
Connection Strength
0.047
-
Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. Diabetes Care. 2022 02 01; 45(2):372-380.
Score: 0.047